Here's Why GSK (GSK) is a Strong Momentum Stock
https://www.zacks.com/stock/news/2310016/here-s-why-gsk-gsk-is-a-strong-momentum-stock?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2310016
Jul 26, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
GSK Blenrep Combos for Multiple Myeloma Accepted for EU Review
https://www.zacks.com/stock/news/2306184/gsk-blenrep-combos-for-multiple-myeloma-accepted-for-eu-review?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2306184
Jul 22, 2024 - GSK announces the acceptance of its regulatory filing, seeking the approval of Blenrep combinations for the treatment of relapsed or refractory multiple myeloma, for review in the EU.
0
Top Research Reports for Apple, Lowe's & Shopify
https://www.zacks.com/commentary/2303621/top-research-reports-for-apple-lowe-s-shopify?cid=CS-ZC-FT-research_daily-2303621
Jul 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Lowe's Companies, Inc. (LOW) and Shopify Inc. (SHOP), as well as two micro-cap stocks MIND Technology, Inc. (MIND) and Moving iMage Technologies, Inc. (MITQ).
0
Is GSK a Top Value Stock Right Now?
https://www.fool.com/investing/2024/07/17/is-gsk-a-top-value-stock-right-now/?source=iedfolrf0000001
Jul 17, 2024 - GSK, a multinational pharma company, scans as a bargain.
0
GSK to deliver over 36M flu shots for fall immunization drive
https://seekingalpha.com/news/4123620-gsk-deliver-36m-flu-shots-this-season?source=feed_sector_healthcare
Jul 11, 2024 - GSK (GSK) plans to distribute over 36M doses of influenza vaccines in the U.S. Read more here.
0
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
https://www.zacks.com/stock/news/2299157/is-gsk-an-attractive-drug-stock-to-add-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2299157
Jul 10, 2024 - Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates make the stock attractive
0
GSK downgraded to Neutral at UBS
https://seekingalpha.com/news/4122606-gsk-downgraded-to-neutral-at-ubs?source=feed_sector_healthcare
Jul 08, 2024 - GSK stock downgraded to Neutral by UBS due to uncertainty on Zantac resolution timing despite strong franchises and valuation.
0
CureVac: GSK's Deal For Infectious Disease Assets Is A Long-Shot For Both Pharmas
https://seekingalpha.com/article/4702471-curevac-gsks-deal-is-a-long-shot?source=feed_tag_editors_picks
Jul 04, 2024 - CureVac's share price has plummeted over 90% in the past five years due to vaccine efficacy issues and legal disputes. Learn why I have a sell rating on CVAC.
0
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
https://www.zacks.com/stock/news/2296893/gsk-buys-flu-covid-mrna-jab-rights-from-partner-curevac?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2296893
Jul 04, 2024 - GSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration deal into a licensing agreement related to mRNA vaccine candidates for COVID-19 and influenza.
0
GSk snaps six straight days of losses
https://seekingalpha.com/news/4122166-gsk-snaps-six-straight-days-of-losses?source=feed_sector_healthcare
Jul 03, 2024 - GSK (GSK) shares rose 0.62% on Wednesday after six consecutive days of losses.
0